Fortis Healthcare Limited
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and he… Read more
Fortis Healthcare Limited (FORTIS) - Net Assets
Latest net assets as of September 2025: ₹96.93 Billion INR
Based on the latest financial reports, Fortis Healthcare Limited (FORTIS) has net assets worth ₹96.93 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹150.13 Billion) and total liabilities (₹53.20 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹96.93 Billion |
| % of Total Assets | 64.57% |
| Annual Growth Rate | 25.97% |
| 5-Year Change | 36.49% |
| 10-Year Change | 90.62% |
| Growth Volatility | 132.77 |
Fortis Healthcare Limited - Net Assets Trend (2002–2025)
This chart illustrates how Fortis Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fortis Healthcare Limited (2002–2025)
The table below shows the annual net assets of Fortis Healthcare Limited from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹91.69 Billion | +7.17% |
| 2024-03-31 | ₹85.56 Billion | +5.63% |
| 2023-03-31 | ₹81.00 Billion | +15.58% |
| 2022-03-31 | ₹70.08 Billion | +4.32% |
| 2021-03-31 | ₹67.18 Billion | -6.77% |
| 2020-03-31 | ₹72.06 Billion | +1.31% |
| 2019-03-31 | ₹71.12 Billion | +33.77% |
| 2018-03-31 | ₹53.17 Billion | -15.75% |
| 2017-03-31 | ₹63.11 Billion | +31.19% |
| 2016-03-31 | ₹48.10 Billion | -1.24% |
| 2015-03-31 | ₹48.71 Billion | -4.34% |
| 2014-03-31 | ₹50.92 Billion | -5.75% |
| 2013-03-31 | ₹54.02 Billion | +32.25% |
| 2012-03-31 | ₹40.85 Billion | +20.42% |
| 2011-03-31 | ₹33.92 Billion | +61.54% |
| 2010-03-31 | ₹21.00 Billion | +56.69% |
| 2009-03-31 | ₹13.40 Billion | -5.31% |
| 2008-03-31 | ₹14.15 Billion | +135.30% |
| 2007-03-31 | ₹6.01 Billion | +82.69% |
| 2006-03-31 | ₹3.29 Billion | +647.95% |
| 2005-03-31 | ₹440.20 Million | +21.39% |
| 2004-03-31 | ₹362.64 Million | +26.49% |
| 2003-03-31 | ₹286.70 Million | -36.67% |
| 2002-03-31 | ₹452.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fortis Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 680466800000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹6.54 Billion | 7.34% |
| Common Stock | ₹7.55 Billion | 8.47% |
| Other Comprehensive Income | ₹2.90 Billion | 3.26% |
| Other Components | ₹72.17 Billion | 80.94% |
| Total Equity | ₹89.17 Billion | 100.00% |
Fortis Healthcare Limited Competitors by Market Cap
The table below lists competitors of Fortis Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tempus AI
F:F3M
|
$4.75 Billion |
|
Paylocity Holdng
NASDAQ:PCTY
|
$4.76 Billion |
|
Bank of Chengdu Co Ltd
SHG:601838
|
$4.76 Billion |
|
Showa Denko K.K
PINK:SHWDF
|
$4.76 Billion |
|
Boot Barn Holdings Inc
NYSE:BOOT
|
$4.75 Billion |
|
NewMarket Corporation
NYSE:NEU
|
$4.75 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
$4.75 Billion |
|
Elia Group SA/NV
OTCGREY:ELIAF
|
$4.74 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fortis Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 76,628,969,000 to 89,165,200,000, a change of 12,536,231,000 (16.4%).
- Net income of 7,742,152,000 contributed positively to equity growth.
- Dividend payments of 1,088,700,000 reduced retained earnings.
- Other comprehensive income increased equity by 24,456,000.
- Other factors increased equity by 5,858,323,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹7.74 Billion | +8.68% |
| Dividends Paid | ₹1.09 Billion | -1.22% |
| Other Comprehensive Income | ₹24.46 Million | +0.03% |
| Other Changes | ₹5.86 Billion | +6.57% |
| Total Change | ₹- | 16.36% |
Book Value vs Market Value Analysis
This analysis compares Fortis Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.11x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1194.54x to 7.11x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-03-31 | ₹0.70 | ₹839.75 | x |
| 2003-03-31 | ₹0.45 | ₹839.75 | x |
| 2004-03-31 | ₹0.34 | ₹839.75 | x |
| 2005-03-31 | ₹0.35 | ₹839.75 | x |
| 2006-03-31 | ₹4.83 | ₹839.75 | x |
| 2007-03-31 | ₹9.04 | ₹839.75 | x |
| 2008-03-31 | ₹21.64 | ₹839.75 | x |
| 2009-03-31 | ₹20.47 | ₹839.75 | x |
| 2010-03-31 | ₹32.07 | ₹839.75 | x |
| 2011-03-31 | ₹52.20 | ₹839.75 | x |
| 2012-03-31 | ₹50.52 | ₹839.75 | x |
| 2013-03-31 | ₹68.02 | ₹839.75 | x |
| 2014-03-31 | ₹76.90 | ₹839.75 | x |
| 2015-03-31 | ₹73.25 | ₹839.75 | x |
| 2016-03-31 | ₹72.47 | ₹839.75 | x |
| 2017-03-31 | ₹79.87 | ₹839.75 | x |
| 2018-03-31 | ₹63.07 | ₹839.75 | x |
| 2019-03-31 | ₹102.49 | ₹839.75 | x |
| 2020-03-31 | ₹88.23 | ₹839.75 | x |
| 2021-03-31 | ₹81.06 | ₹839.75 | x |
| 2022-03-31 | ₹81.84 | ₹839.75 | x |
| 2023-03-31 | ₹95.93 | ₹839.75 | x |
| 2024-03-31 | ₹101.50 | ₹839.75 | x |
| 2025-03-31 | ₹118.16 | ₹839.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fortis Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.68%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.94%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.54x
- Recent ROE (8.68%) is above the historical average (-8.22%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -51.90% | -197.69% | 0.09x | 2.86x | ₹-280.23 Million |
| 2003 | -69.89% | -51.56% | 0.27x | 5.03x | ₹-229.05 Million |
| 2004 | -31.52% | -14.01% | 0.46x | 4.84x | ₹-90.66 Million |
| 2005 | -37.88% | -11.64% | 0.53x | 6.15x | ₹-108.49 Million |
| 2006 | -18.54% | -19.72% | 0.28x | 3.30x | ₹-888.31 Million |
| 2007 | -16.85% | -19.15% | 0.38x | 2.33x | ₹-1.56 Billion |
| 2008 | -3.98% | -10.94% | 0.26x | 1.41x | ₹-1.95 Billion |
| 2009 | 1.58% | 3.30% | 0.31x | 1.57x | ₹-1.11 Billion |
| 2010 | 3.36% | 7.41% | 0.12x | 3.84x | ₹-1.37 Billion |
| 2011 | 3.70% | 8.39% | 0.31x | 1.44x | ₹-2.12 Billion |
| 2012 | 2.22% | 2.42% | 0.24x | 3.82x | ₹-2.53 Billion |
| 2013 | 11.07% | 15.94% | 0.22x | 3.10x | ₹469.11 Million |
| 2014 | 2.47% | 3.51% | 0.44x | 1.59x | ₹-3.73 Billion |
| 2015 | -3.05% | -3.62% | 0.52x | 1.61x | ₹-6.15 Billion |
| 2016 | 0.39% | 0.44% | 0.58x | 1.55x | ₹-4.48 Billion |
| 2017 | 8.20% | 9.22% | 0.47x | 1.89x | ₹-926.84 Million |
| 2018 | -24.85% | -22.13% | 0.53x | 2.12x | ₹-14.15 Billion |
| 2019 | -4.53% | -6.69% | 0.37x | 1.81x | ₹-9.59 Billion |
| 2020 | 0.87% | 1.25% | 0.41x | 1.70x | ₹-6.08 Billion |
| 2021 | -1.79% | -2.72% | 0.36x | 1.82x | ₹-7.22 Billion |
| 2022 | 8.99% | 9.71% | 0.48x | 1.92x | ₹-627.06 Million |
| 2023 | 8.13% | 9.35% | 0.51x | 1.72x | ₹-1.35 Billion |
| 2024 | 7.82% | 8.68% | 0.52x | 1.73x | ₹-1.67 Billion |
| 2025 | 8.68% | 9.94% | 0.57x | 1.54x | ₹-1.17 Billion |
Industry Comparison
This section compares Fortis Healthcare Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $9,565,531,917
- Average return on equity (ROE) among peers: 7.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fortis Healthcare Limited (FORTIS) | ₹96.93 Billion | -51.90% | 0.55x | $4.75 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $48.02 Billion | 3.13% | 1.38x | $8.78 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $8.87 Billion | 5.90% | 0.85x | $1.44 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $38.32 Million |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $306.37 Million |
| Indraprastha Medical Corporation Limited (INDRAMEDCO) | $1.59 Billion | 16.95% | 1.52x | $188.50 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.37 Billion | 12.52% | 1.55x | $349.01 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $14.11 Billion | 23.58% | 0.35x | $1.73 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $7.56 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $5.49 Billion | -11.78% | 1.33x | $7.97 Billion |